Cargando…

Evolutional transition of HBV genome during the persistent infection determined by single-molecule real-time sequencing

Although HBV infection is a serious health issue worldwide, the landscape of HBV genome dynamics in the host has not yet been clarified. This study aimed to determine the continuous genome sequence of each HBV clone using a single-molecule real-time sequencing platform, and clarify the dynamics of s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arasawa, Soichi, Takeda, Haruhiko, Takai, Atsushi, Iguchi, Eriko, Eso, Yuji, Shimizu, Takahiro, Takahashi, Ken, Yamashita, Taiki, Ueda, Yoshihide, Marusawa, Hiroyuki, Seno, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974078/ https://www.ncbi.nlm.nih.gov/pubmed/36848123 http://dx.doi.org/10.1097/HC9.0000000000000047

Ejemplares similares

DNA methyltransferase 3B plays a protective role against hepatocarcinogenesis caused by chronic inflammation via maintaining mitochondrial homeostasis
por: Iguchi, Eriko, et al.
Publicado: (2020)

Author Correction: DNA methyltransferase 3B plays a protective role against hepatocarcinogenesis caused by chronic inflammation via maintaining mitochondrial homeostasis
por: Iguchi, Eriko, et al.
Publicado: (2021)

Mutational spectrum of hepatitis C virus in patients with chronic hepatitis C determined by single molecule real-time sequencing
por: Nakamura, Fumiyasu, et al.
Publicado: (2022)

Expansion of viral variants associated with immune escape and impaired virion secretion in patients with HBV reactivation after resolved infection
por: Inuzuka, Tadashi, et al.
Publicado: (2018)

Microsatellite instability and immune checkpoint inhibitors: toward precision medicine against gastrointestinal and hepatobiliary cancers
por: Eso, Yuji, et al.
Publicado: (2019)

Dose Intensity/Body Surface Area Ratio is a Novel Marker Useful for Predicting Response to Lenvatinib against Hepatocellular Carcinoma
por: Eso, Yuji, et al.
Publicado: (2019)

Genetic Landscape of Multistep Hepatocarcinogenesis
por: Takeda, Haruhiko, et al.
Publicado: (2022)

Combination of Mac-2 Binding Protein Glycosylation Isomer and Up-To-Seven Criteria as a Useful Predictor for Child-Pugh Grade Deterioration after Transarterial Chemoembolization for Hepatocellular Carcinoma
por: Eso, Yuji, et al.
Publicado: (2019)

Single-molecular real-time deep sequencing reveals the dynamics of multi-drug resistant haplotypes and structural variations in the hepatitis C virus genome
por: Yamashita, Taiki, et al.
Publicado: (2020)

Clinical and Molecular Basis of Hepatocellular Carcinoma after Hepatitis C Virus Eradication
por: Oe, Natsumi, et al.
Publicado: (2022)

Accelerated Progression of Hepatocellular Carcinoma during Immunosuppressive Therapy with Abatacept for Rheumatoid Arthritis
por: Yoshiji, Satoshi, et al.
Publicado: (2018)

Pretreatment Neutrophil-to-Lymphocyte Ratio as a Predictive Marker of Response to Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma
por: Eso, Yuji, et al.
Publicado: (2021)

Exploring the hepatitis C virus genome using single molecule real-time sequencing
por: Takeda, Haruhiko, et al.
Publicado: (2019)

Evolution of multi-drug resistant HCV clones from pre-existing resistant-associated variants during direct-acting antiviral therapy determined by third-generation sequencing
por: Takeda, Haruhiko, et al.
Publicado: (2017)

Hepatitis-associated Aplastic Anemia with Rapid Progression of Liver Fibrosis Due to Repeated Hepatitis
por: Sawada, Kenji, et al.
Publicado: (2019)

Exploring the Mechanisms of Gastrointestinal Cancer Development Using Deep Sequencing Analysis
por: Matsumoto, Tomonori, et al.
Publicado: (2015)

Recent Advances in Immunotherapy for Hepatocellular Carcinoma
por: Nakano, Shigeharu, et al.
Publicado: (2020)

Genetic Pathogenesis of Inflammation-Associated Cancers in Digestive Organs
por: Nakanishi, Risa, et al.
Publicado: (2021)

Current status of treatment with immune checkpoint inhibitors for gastrointestinal, hepatobiliary, and pancreatic cancers
por: Eso, Yuji, et al.
Publicado: (2020)

Risk factors and diagnostic biomarkers for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: Current evidence and future perspectives
por: Ueno, Masayuki, et al.
Publicado: (2022)

Acquisition of Genetic Aberrations by Activation-Induced Cytidine Deaminase (AID) during Inflammation-Associated Carcinogenesis
por: Takai, Atsushi, et al.
Publicado: (2011)

Acute Anorectal Thrombophlebitis Caused by a Protein C Deficiency
por: Eso, Yuji, et al.
Publicado: (2017)

Detectable HBV DNA during nucleos(t)ide analogues stratifies predictive hepatocellular carcinoma risk score
por: Kaneko, Shun, et al.
Publicado: (2020)

Long-term Prognosis and Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: A Single-Center Experience
por: Ueda, Yoshihide, et al.
Publicado: (2017)

Genetic Heterogeneity of Hepatitis C Virus in Association with Antiviral Therapy Determined by Ultra-Deep Sequencing
por: Nasu, Akihiro, et al.
Publicado: (2011)

Establishment of a system for finding inhibitors of ε RNA binding with the HBV polymerase
por: Liu, Xiao‐Quan, et al.
Publicado: (2020)

Anti-integrin αvβ6 autoantibodies in patients with primary sclerosing cholangitis
por: Yoshida, Hiroyuki, et al.
Publicado: (2023)

Choledochoduodenal Fistula during Chemotherapy with Brentuximab Vedotin for Methotrexate-associated Lymphoproliferative Disorder
por: Eso, Yuji, et al.
Publicado: (2018)

Targeting Angiogenesis for Advanced Hepatocellular Carcinoma
por: Eso, Yuji
Publicado: (2020)

Update Treatment for HBV Infection and Persistent Risk for Hepatocellular Carcinoma: Prospect for an HBV Cure
por: Yoo, Joseph, et al.
Publicado: (2018)

Utility of KRAS mutational analysis in the preoperative diagnosis of synchronous pancreatic cancer and intrahepatic cholangiocarcinoma: A case report
por: Eso, Yuji, et al.
Publicado: (2017)

Dynamics of Hepatitis B Virus Quasispecies in Association with Nucleos(t)ide Analogue Treatment Determined by Ultra-Deep Sequencing
por: Nishijima, Norihiro, et al.
Publicado: (2012)

The progress of molecules and strategies for the treatment of HBV infection
por: Pan, Youlu, et al.
Publicado: (2023)

Sorafenib-induced acute interstitial pneumonia in patients with advanced hepatocellular carcinoma: report of three cases
por: Takeda, Haruhiko, et al.
Publicado: (2012)

Hepadnaviral Lymphotropism and Its Relevance to HBV Persistence and Pathogenesis
por: Coffin, Carla S., et al.
Publicado: (2021)

Pretransplant Serum Hepatitis C Virus RNA Levels Predict Response to Antiviral Treatment after Living Donor Liver Transplantation
por: Ueda, Yoshihide, et al.
Publicado: (2013)

Correction: Pretransplant Serum Hepatitis C Virus RNA Levels Predict Response to Antiviral Treatment after Living Donor Liver Transplantation
por: Ueda, Yoshihide, et al.
Publicado: (2013)

Epigenetic reprogramming promotes the antiviral action of IFNα in HBV-infected cells
por: Gailhouste, Luc, et al.
Publicado: (2021)

Enhanced antiviral and antifibrotic effects of short hairpin RNAs targeting HBV and TGF-β in HBV-persistent mice
por: Ye, Lei, et al.
Publicado: (2017)

TNF‐α polymorphisms affect persistence and progression of HBV infection
por: Woziwodzka, Anna, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jclh6mounjhf6t4kk6pagkq8i9